Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001181431-13-045370

Options or other derivatives

  • Director acquired 170,000.74 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HedgePath, LLC Director 2013-08-13 Grant or award · Series A Convertible Preferred Stock +170,000.74 170,000.74 D
Loading xslF345X03/rrd388585.xml…